May 13, 2021 4:55pm EDT Processa Pharmaceuticals Announces First Quarter 2021 Results and Provides Corporate Update
May 07, 2021 8:30am EDT Processa Pharmaceuticals Schedules Conference Call to Discuss First Quarter Results and Provide Drug Development Update on May 13 at 5:30 p.m. EST
Mar 25, 2021 4:06pm EDT Processa Pharmaceuticals Announces Year end 2020 Results and Provides Corporate Update
Mar 22, 2021 9:15am EDT Processa Pharmaceuticals Schedules Conference Call to Discuss Fourth Quarter Results and Provide Drug Development Update on March 25 at 5:30 p.m. ET
Mar 17, 2021 9:15am EDT Processa Announces Sites Selected for Phase 2B Clinical Trial to Treat Patients with Ulcerated Necrobiosis Lipoidica
Mar 02, 2021 9:15am EST Processa Pharmaceuticals Announces Closing of a $10.2 Million Private Placement
Jan 11, 2021 10:50am EST Processa Pharmaceuticals to Present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference
Nov 12, 2020 5:02pm EST Processa Pharmaceuticals Announces Third Quarter 2020 Results, Provides Corporate Update
